Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Palleon Pharmaceuticals
4367
Palleon Pharmaceuticals
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Palleon is targeting glycan-sensing checkpoints to unleash both the innate and adaptive immune responses to cancer.
Suggest edits
Founded
2016
Raised
$148M
Follow us
Companies in the same industry
Takeda Pharmaceutical Company Ltd
Neuraltus Pharmaceuticals
molecular assemblies
Esperion Therapeutics
Amplyx Pharmaceuticals, Inc
VG Life Sciences
Egalet Corporation
MicuRx Pharmaceuticals, Inc.
Laboratoires Majorelle
Aura Biosciences
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$100,000,000
Venture capital (Series B) - 2020
SR One
Matrix Capital Management
Takeda Ventures
+5
$48,000,000
Venture capital (Series A) - 2017
SR One
AbbVie Biotech Ventures
Pfizer Venture Investments
+5
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$100,000,000
Venture capital (Series B)
FinSMEs
Palleon Pharmaceuticals Raises $100M in Series B Funding
$48,000,000
Venture capital (Series A)
Xconomy
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug
Health
Science
Funding
